Position in BNTX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$3,442
+$154 QoQ
Shares Held
37
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#255
of 284 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Asset Dedication, LLC holds $189,361 across 9 Biotechnology names. BNTX ranks #3 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
237 | $117,725 | |
| 2 | MRNA |
Moderna, Inc.
|
843 | $59,035 | |
| 3 | BNTX |
BioNTech SE
This page
|
37 | $3,442 | |
| 4 | RPRX |
Royalty Pharma plc
|
49 | $2,747 | |
| 5 | NNVC |
Nanoviricides, Inc.
|
1,450 | $2,001 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6 | $1,806 | |
| 7 | PRTA |
Prothena Corp Public Ltd Co
|
184 | $1,801 | |
| 8 | NVAX |
Novavax Inc
|
65 | $612 |
All Filings in BNTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,442 | 37 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $3,288 | 37 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $3,522 | 37 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $3,648 | 37 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $3,939 | 37 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $3,369 | 37 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $4,671 | 41 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $4,869 | 41 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $3,294 | 41 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||